StonvexLoading…
StonvexStonvexStonvexCore line items from ESS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $9.38M | $10.27M | $11.13M | $11.14M |
Operating Income | $899.32M | $703.10M | $584.34M | $595.23M |
Net Income | $702.77M | $811.31M | $430.71M | $432.99M |
EPS (Diluted) | $10.40 | $11.54 | $6.32 | $6.27 |
Total Assets | $13.16B | $12.93B | $12.36B | $12.37B |
Total Liabilities | $7.42B | $7.18B | $6.74B | $6.45B |
Cash & Equivalents | $76.24M | $66.80M | $391.75M | $33.30M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 64.44M | 64.28M | 64.20M | 64.60M |